Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AURX | US
0.13
8.28%
Healthcare
Biotechnology
30/06/2024
08/04/2026
1.70
1.58
1.70
1.58
Nuo Therapeutics Inc. a regenerative therapies company develops commercializes and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix Inc. and changed its name to Nuo Therapeutics Inc. in November 2014. Nuo Therapeutics Inc. was incorporated in 1998 and is based in Houston Texas.
View LessStrength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Strong Revenue Growth (> 10%)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Low negative Beta, possible Low Liquidity (< -0.4)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
168.3%1 month
126.3%3 months
118.1%6 months
103.6%-
-
46.71
-
-
-67.38
26.91
-
-2.68M
79.22M
79.22M
-
-148.58
-
208.70
-503.61
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.40
Range1M
0.66
Range3M
1.06
Rel. volume
2.07
Price X volume
15.66K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Surrozen Inc. Common Stock | SRZN | Biotechnology | 25.93 | 83.13M | 0.62% | n/a | 35.73% |
| Pliant Therapeutics Inc. | PLRX | Biotechnology | 1.36 | 82.69M | 3.82% | n/a | 15.34% |
| iShares MSCI Brazil ETF USD Acc | CSBR | Biotechnology | 6.03 | 81.97M | -1.79% | n/a | -2140.66% |
| Humacyte Inc | HUMA | Biotechnology | 0.6515 | 81.65M | 7.35% | n/a | -63.37% |
| Cassava Sciences Inc | SAVA | Biotechnology | 1.7 | 81.56M | 1.80% | n/a | 0.00% |
| Mawson Infrastructure Group Inc. Common Stock | MIGI | Biotechnology | 4.26 | 79.04M | 48.95% | n/a | 571.64% |
| Gossamer Bio Inc | GOSS | Biotechnology | 0.3474 | 78.59M | 5.37% | n/a | 243.93% |
| Fortress Biotech Inc | FBIOP | Biotechnology | 13.89 | 74.56M | 1.76% | n/a | 494.61% |
| Tenaya Therapeutics Inc. Common Stock | TNYA | Biotechnology | 0.7252 | 74.08M | 8.63% | n/a | 11.62% |
| CRDF | CRDF | Biotechnology | 1.56 | 72.62M | 0.00% | n/a | 3.52% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Saga Communications Inc | SGA | Broadcasting - Radio | 11.8 | 73.89M | 1.72% | 14.48 | 7.10% |
| ILAG | ILAG | Building Products & Equipment | 3.4 | 61.40M | -6.85% | n/a | 5.48% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.21 | 17.68M | 4.31% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.6564 | 12.68M | 0.37% | n/a | 58.43% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 5.67 | 8.64M | 80.57% | n/a | 204.46% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.264 | 3.23M | 2.35% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.2692 | 2.56M | 21.37% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.02 | 1.11M | -0.98% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -67.38 | - | Cheaper |
| Ent. to Revenue | 26.91 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 46.71 | 15.55 | Expensive |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 118.09 | - | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 79.22M | - | Emerging |